Assertio Holdings, Inc., commonly referred to as Assertio, is a prominent biopharmaceutical company headquartered in the United States. Founded in 2013, Assertio has established itself within the specialty pharmaceutical industry, focusing on the development and commercialisation of innovative treatments for pain management and neurology. With a strong operational presence across North America, Assertio is renowned for its unique portfolio of prescription medications, including its flagship product, Zipsor, which offers a novel approach to pain relief. The company has achieved significant milestones, including strategic acquisitions that have bolstered its market position and expanded its therapeutic offerings. Assertio's commitment to improving patient outcomes through targeted therapies underscores its reputation as a leader in the biopharmaceutical sector.
How does Assertio Holdings, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Assertio Holdings, Inc.'s score of 25 is lower than 63% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Assertio Holdings, Inc., headquartered in the US, currently does not have available carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, the company has not established any documented reduction targets or climate pledges. This lack of data suggests that Assertio Holdings may be in the early stages of developing its climate strategy or reporting framework. As of now, there are no emissions inherited from a parent company, and all data is sourced directly from Assertio Holdings, Inc. Without specific emissions figures or reduction initiatives, it is challenging to assess the company's climate commitments or performance in relation to industry standards.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Assertio Holdings, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

